Compare HCA Health Inc (HCA) vs The Coca-Cola Co K (KO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs The Coca-Cola Co K — how do they compare? HCA Health Inc trades at $443.69 (market cap $95.08B), while The Coca-Cola Co K trades at $87.5 (market cap $369.24B). The key difference: The Coca-Cola Co K is far larger — about 3.9× HCA Health Inc's market cap, and The Coca-Cola Co K pays the higher dividend (2.47%). Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and The Coca-Cola Co K for 154 Days on average.
| HCA | KO | |
|---|---|---|
Market Cap | $95.08B | $369.24B |
Volume | 998,787 | 12,951,290 |
Sector | Health | Consumer Staples |
52-Week High | $545.13 | $91.99 |
52-Week Low | $361.32 | $66.37 |
Typical Hold Time | 76 Days | 154 Days |
Enterprise Value | $145.62B | $396.42B |
Dividend Yield | 0.71% | 2.47% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare (HCA) trades at $445.01, up 2.96% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $75.6B in 2025, with net income of $6.78B, and the stock trades at a P/E of 14.73. Analyst consensus is a Buy with a $461.12 price target, though ongoing legal investigations pose a headwind.
The outlook remains positive given solid demand and cost controls, but risks include payer-mix pressure and high debt levels. Upside potential exists if earnings growth continues, but investors should monitor legal developments and interest rate impacts on the leveraged balance sheet.
Coca-Cola (KO) trades at $87.77, up 1.86% today, with a bearish technical signal despite recent earnings beats. The stock shows strong profitability with a 28.56% net income margin and 44.23% ROE, supported by consistent revenue growth. Analyst consensus is bullish with a $95.75 price target, though technical indicators highlight near-term resistance at $86-$87. Recent news highlights institutional buying and stable demand trends ahead of Q3 earnings.
The outlook remains positive given KO's dividend track record and earnings momentum, but risks include regional demand volatility and high debt levels. Upside is supported by analyst targets, while technical weakness near key resistance may limit short-term gains. The stock offers value for income-focused investors despite macroeconomic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About The Coca-Cola Co K
The Coca-Cola Company manufactures, markets, and distributes soft drink concentrates and syrups. The Company also distributes and markets juice and juice-drink products. Coca-Cola distributes its products to retailers and wholesalers in the United States and internationally.
Read more on KO →
